"Designing Growth Strategies is in our DNA"

Mental Health Screening Market Size, Share & Industry Analysis, By Platform (mHealth, Remote Platform, Telehealth, & Others), By Assessment Type (Self-reported Questionnaires, Clinical Interviews, Observational Tools, & Biomarker Tools), By Disease Indication (Depression, Alzheimer’s, OCD, Anxiety disorders, PTSD, ADHD, Schizophrenia, Sleep Disorders), By Age Group (Pediatric & Adults), By Application (Diagnostic, Clinical Trials, Training & Assessments), By Setting (Clinical Settings, Educational Institutions, Workplace/corporate Programs, Online Platforms), and Regional Forecast, 2026-2034

Last Updated: January 06, 2026 | Format: PDF | Report ID: FBI115036

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 11.31% from 2026-2034

Unit

Value (USD Billion)

Segmentation

By Platform, Assessment Type, Disease Indication, Age Group, Application, Setting, and Region

By Platform

·         mHealth

·         Remote Platform

·         Telehealth

·         Others

By Assessment Type

·         Self-reported Questionnaires

·         Clinical Interviews

·         Observational Tools

·         Biomarker Tools

By Disease Indication

·         Depression

·         Alzheimer’s

·         OCD

·         Anxiety disorders

·         PTSD

·         ADHD

·         Schizophrenia

·         Sleep Disorders

·         Others

By Age Group

·         Pediatric

·         Adults

By Application

·         Diagnostic

·         Clinical Trials

·         Training and Assessments

·         Others

By Setting

·         Clinical Settings

·         Educational Institutions

·         Workplace/corporate Programs

·         Online Platforms

·         Others

By Region

·         North America (By Platform, Assessment Type, Disease Indication, Age Group, Application, Setting, and Country)

o   U.S.

o   Canada

·         Europe (By Platform, Assessment Type, Disease Indication, Age Group, Application, Setting, and Country/Sub-region)

o   Germany

o   U.K.

o   France

o   Spain

o   Italy

o   Scandinavia

o   Rest of Europe

·         Asia Pacific (By Platform, Assessment Type, Disease Indication, Age Group, Application, Setting, and Country/Sub-region)

o   China

o   Japan

o   India

o   Australia

o   Southeast Asia

o   Rest of Asia Pacific

·         Latin America (By Platform, Assessment Type, Disease Indication, Age Group, Application, Setting, and Country/Sub-region)

o   Brazil

o   Mexico

o   Rest of Latin America

·         Middle East & Africa (By Platform, Assessment Type, Disease Indication, Age Group, Application, Setting, and Country/Sub-region)

o   GCC

o   South Africa

o   Rest of Middle East & Africa

 

  • 2021-2034
  • 2025
  • 2021-2030
  • 200
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann